Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

ValiRx shares jump as H1 losses shrink

(Sharecast News) - Shares in ValiRx jumped nearly on Thursday after the biotech posted results for its first half, in which losses per share shrunk by a third. ValiRx, which provides the scientific, financial and commercial framework for clinical development in cancer and women's health, said the losses from continuing operations totalled 1.03p per share in the six months to 30 June, down from 1.53p a year earlier.

The company, which is transforming itself into a so-called translational contract research organisation (tCRO), launched its service-providing subsidiary Inaphaea during the first half, which made its first external sales since the period-end.

"Having shifted the tCRO® strategy towards a build-and-buy approach in the latter part of 2022, the primary activity in the first half of 2023 has been to establish in-house, cell-based testing capabilities to support both our collaborative development pipeline and generate income through third-party business," said chief executive Susanne Dilly.

The pre-tax loss for the period totalled £1.15m, compared with £1.07m the year before, after accounting for integration costs of recent acquisitions.

Cash and cash equivalents stood at £891,246 by the end of the first half, signficantly up from £97,699 a year earlier.

The stock was up 7.4% at 6.55p by 1041 BST.

Share this article

Related Sharecast Articles

ProCook delivers 'strong trading performance' in FY25
(Sharecast News) - UK kitchenware brand ProCook said on Wednesday that it had delivered a "strong trading performance" in the year ended 30 March, significantly outperforming the market.
S&U trending ahead of FY24, awaits Supreme Court verdict
(Sharecast News) - Specialist lender S&U said on Wednesday that its optimism in its FY results was "gradually and clearly being justified" by the group's recent performance, particularly over the past two months.
Wood Group and Sidara granted further extension to PUSU deadline
(Sharecast News) - Wood Group has been granted an extension to the so-called 'put up or shut up' takeover deadline for Sidara until 30 June as part of an effort to push the deal through before the end of the month.
Tullow Oil enters MOU to extend Ghanaian licences
(Sharecast News) - Exploration firm Tullow Oil revealed on Wednesday that it had entered into a Memorandum of Understanding to extend the West Cape Three Points and Deep Water Tano licences to 2040.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.